Technical Data
C3800
Chartreusin (Lambdamycin, NSC 5159, Antibiotic 747, Antibiotic 1293, Antibiotic X465A, Antibiotic G 261A)
5mg
|
Technical Data |
|
C3800 |
Chartreusin (Lambdamycin, NSC 5159, Antibiotic 747, Antibiotic 1293, Antibiotic X465A, Antibiotic G 261A) |
5mg |
| Biochemicals | Storage: 4°C/-20°CShipping: Blue Ice |
|
Chartreusin is an antitumor antibiotic that binds to GC-rich tracts in DNA, with a clear preference for B-DNA over Z-DNA. It inhibits RNA synthesis and causes single-strand scission of DNA via the formation of free radicals. Chartreusin is also potent inhibitor of topoisomerase II. DMSO and DMF, partially soluble in methanol and ethanol while poorly soluble in water CAS Number: 6377-18-0 Molecular Formula: C32H32O14 Molecular Weight: 640.59600000000000364 |
Source: Streptomyces sp. Purity: >99% Form: Yellow solid Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Chartreusin, a new antibiotic produced by Streptomyces chartreusis, a new species. Leach, B.E. et al., J.Am.Chem.Soc. 1953, 75, 4011. 2. Biochemical characterisation of elsamicin and other coumarin-related antitumor agents as potent inhibitors of topoisomerase II. Lorico A. and Long B.H. Eur. J. Cancer 1993, 14, 1985. 3. Chartreusin, elsamicin A and related anti-cancer antibiotics. Portugal J. Curr. Med. Chem. Anticancer Agents. 2003, 3, 411.
|
||